• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

tRF-Glu-CTC-013作为心脏肥大发展中的生物标志物和关键调节因子的筛选与评估

Screening and Evaluation of tRF-Glu-CTC-013 as a Biomarker and Key Regulator in the Development of Cardiac Hypertrophy.

作者信息

Li Wenlin, Lan Ming, Xu Kun, Li Sainan, Wang Que, Chen Beidong, Huang Xiuqing, Dou Lin, Jia Na, Zhao Li, Wang Yuefeng, Jiao Xingyun, Man Yong, Liu Deping, Sun Liang, Zou Tong, He Qing, Li Jian, Yu Xue, Shen Tao

机构信息

The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology of National Health Commission, Beijing 100730, China.

Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.

出版信息

Int J Med Sci. 2025 Jun 9;22(11):2839-2851. doi: 10.7150/ijms.106114. eCollection 2025.

DOI:10.7150/ijms.106114
PMID:40520901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12163609/
Abstract

tRNA-derived small RNAs (tsRNAs) are a newly recognized class of non-coding RNAs involved in regulating RNA processing and translational control. Pathological cardiac hypertrophy, characterized by left ventricular remodeling under chronic stress, serves as a critical precursor to severe cardiovascular pathologies including myocardial ischemia, infarction, and heart failure. Utilizing an angiotensin II (Ang II)-induced mouse cardiac hypertrophy model combined with tsRNA transcriptome profiling, we identified differentially expressed tsRNAs and investigated their functional relevance. Validation in neonatal mouse ventricular myocytes (NMVMs) revealed five upregulated tsRNAs associated with hypertrophic progression. Functional characterization showed that overexpressing tRF-Glu-CTC-013 significantly reduced cardiomyocyte hypertrophy and inhibited inflammation and fibrosis. Further luciferase reporter assays revealed that tRF-Glu-CTC-013 could bind to the 3' UTR of TAS1R3, thereby inhibiting its expression and enhancing the level of autophagy in NMVMs. Taken together, these findings suggest that tsRNAs may act as novel regulators of cardiac remodeling, with tRF-Glu-CTC-013 emerging as a promising therapeutic candidate for cardioprotection via anti-hypertrophic, anti-inflammatory, and anti-fibrotic mechanisms.

摘要

转运RNA衍生的小RNA(tsRNAs)是一类新发现的非编码RNA,参与调控RNA加工和翻译控制。病理性心脏肥大以慢性应激下的左心室重塑为特征,是包括心肌缺血、梗死和心力衰竭在内的严重心血管疾病的关键先兆。利用血管紧张素II(Ang II)诱导的小鼠心脏肥大模型结合tsRNA转录组分析,我们鉴定了差异表达的tsRNAs,并研究了它们的功能相关性。在新生小鼠心室肌细胞(NMVMs)中的验证揭示了与肥大进展相关的5种上调的tsRNAs。功能表征表明,过表达tRF-Glu-CTC-013可显著减轻心肌细胞肥大,并抑制炎症和纤维化。进一步的荧光素酶报告基因分析表明,tRF-Glu-CTC-013可与TAS1R3的3'UTR结合,从而抑制其表达并提高NMVMs中的自噬水平。综上所述,这些发现表明tsRNAs可能作为心脏重塑的新型调节因子,其中tRF-Glu-CTC-013通过抗肥大、抗炎和抗纤维化机制成为一种有前景的心脏保护治疗候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d05/12163609/dead275919c0/ijmsv22p2839g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d05/12163609/55d45ed93c56/ijmsv22p2839g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d05/12163609/56c17c38fd55/ijmsv22p2839g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d05/12163609/848afd4f7b08/ijmsv22p2839g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d05/12163609/ef20e1e8528a/ijmsv22p2839g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d05/12163609/8f412305eebb/ijmsv22p2839g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d05/12163609/dead275919c0/ijmsv22p2839g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d05/12163609/55d45ed93c56/ijmsv22p2839g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d05/12163609/56c17c38fd55/ijmsv22p2839g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d05/12163609/848afd4f7b08/ijmsv22p2839g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d05/12163609/ef20e1e8528a/ijmsv22p2839g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d05/12163609/8f412305eebb/ijmsv22p2839g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d05/12163609/dead275919c0/ijmsv22p2839g006.jpg

相似文献

1
Screening and Evaluation of tRF-Glu-CTC-013 as a Biomarker and Key Regulator in the Development of Cardiac Hypertrophy.tRF-Glu-CTC-013作为心脏肥大发展中的生物标志物和关键调节因子的筛选与评估
Int J Med Sci. 2025 Jun 9;22(11):2839-2851. doi: 10.7150/ijms.106114. eCollection 2025.
2
Novel therapeutic insights into pathological cardiac hypertrophy: tRF-16-R29P4PE regulates PACE4 and metabolic pathways.病理性心脏肥大的新型治疗见解:tRF-16-R29P4PE调节PACE4和代谢途径。
Biochim Biophys Acta Mol Cell Res. 2025 Mar;1872(3):119920. doi: 10.1016/j.bbamcr.2025.119920. Epub 2025 Feb 11.
3
Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.肥厚型心肌病细胞基因表达谱分析揭示病理重构中的新角色。
Cardiovasc Res. 2021 May 25;117(6):1532-1545. doi: 10.1093/cvr/cvaa233.
4
Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.脂联素介导氧化应激诱导的心肌细胞重构中的心脏保护作用。
Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H984-93. doi: 10.1152/ajpheart.00428.2011. Epub 2011 Jun 10.
5
Melatonin alleviates angiotensin-II-induced cardiac hypertrophy via activating MICU1 pathway.褪黑素通过激活 MICU1 通路缓解血管紧张素-II 诱导的心肌肥厚。
Aging (Albany NY). 2020 Nov 26;13(1):493-515. doi: 10.18632/aging.202159.
6
Transfer RNA-derived small RNA tRF-Glu-CTC attenuates neointimal formation via inhibition of fibromodulin.转移 RNA 衍生的小 RNA tRF-Glu-CTC 通过抑制纤维调节蛋白来减轻新生内膜形成。
Cell Mol Biol Lett. 2024 Jan 3;29(1):2. doi: 10.1186/s11658-023-00523-z.
7
Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.长春西汀通过抑制心肌肥大和纤维化减轻病理性心脏重塑。
Cardiovasc Drugs Ther. 2017 Apr;31(2):157-166. doi: 10.1007/s10557-017-6719-0.
8
Mep1a contributes to Ang II-induced cardiac remodeling by promoting cardiac hypertrophy, fibrosis and inflammation.Mep1a 通过促进心肌肥厚、纤维化和炎症导致 Ang II 诱导的心脏重构。
J Mol Cell Cardiol. 2021 Mar;152:52-68. doi: 10.1016/j.yjmcc.2020.11.015. Epub 2020 Dec 8.
9
MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.miR-92b-3p 通过靶向 HAND2 抑制血管紧张素 II 诱导的心肌细胞肥大。
Life Sci. 2019 Sep 1;232:116635. doi: 10.1016/j.lfs.2019.116635. Epub 2019 Jul 5.
10
Transfer RNA-derived small RNAs (tsRNAs) sequencing revealed a differential expression landscape of tsRNAs between glioblastoma and low-grade glioma.转运RNA衍生的小RNA(tsRNAs)测序揭示了胶质母细胞瘤和低级别胶质瘤之间tsRNAs的差异表达图谱。
Gene. 2023 Mar 1;855:147114. doi: 10.1016/j.gene.2022.147114. Epub 2022 Dec 13.

本文引用的文献

1
Screening and identification of versican as a sensitive biomarker and potential therapeutic target in basal cell carcinoma.多功能蛋白聚糖作为基底细胞癌敏感生物标志物和潜在治疗靶点的筛选与鉴定
Int J Med Sci. 2025 Apr 28;22(10):2488-2501. doi: 10.7150/ijms.105650. eCollection 2025.
2
The dual functions of the pentacyclic triterpenoid madecassic acid in ameliorating doxorubicin-induced cardiotoxicity and enhancing the antitumor efficacy of doxorubicin.五环三萜玛咖酸在改善阿霉素诱导的心脏毒性和增强阿霉素抗肿瘤疗效中的双重作用。
Int J Biol Sci. 2024 Oct 7;20(14):5396-5414. doi: 10.7150/ijbs.97418. eCollection 2024.
3
The function and therapeutic potential of transfer RNA-derived small RNAs in cardiovascular diseases: A review.
转移 RNA 衍生的小 RNA 在心血管疾病中的功能和治疗潜力:综述。
Pharmacol Res. 2024 Aug;206:107279. doi: 10.1016/j.phrs.2024.107279. Epub 2024 Jun 26.
4
DEAD-box helicase 17 (DDX17) protects cardiac function by promoting mitochondrial homeostasis in heart failure.DEAD-box 解旋酶 17(DDX17)通过促进心力衰竭中的线粒体动态平衡来保护心脏功能。
Signal Transduct Target Ther. 2024 May 24;9(1):127. doi: 10.1038/s41392-024-01831-2.
5
TEA domain transcription factor 1(TEAD1) induces cardiac fibroblasts cells remodeling through BRD4/Wnt4 pathway.TEA结构域转录因子1(TEAD1)通过BRD4/Wnt4途径诱导心脏成纤维细胞重塑。
Signal Transduct Target Ther. 2024 Feb 19;9(1):45. doi: 10.1038/s41392-023-01732-w.
6
Non-coding RNAs in disease: from mechanisms to therapeutics.非编码 RNA 在疾病中的作用:从机制到治疗。
Nat Rev Genet. 2024 Mar;25(3):211-232. doi: 10.1038/s41576-023-00662-1. Epub 2023 Nov 15.
7
Expression profiles and functional analysis of tRNA-derived small RNAs in epicardial adipose tissue of patients with heart failure.心力衰竭患者心外膜脂肪组织中 tRNA 衍生的小 RNA 的表达谱和功能分析。
Ann Med. 2023;55(2):2267981. doi: 10.1080/07853890.2023.2267981. Epub 2023 Oct 15.
8
Global Profile of tRNA-Derived Small RNAs in Pathological Cardiac Hypertrophy Plasma and Identification of tRF-21-NB8PLML3E as a New Hypertrophy Marker.病理性心肌肥厚血浆中tRNA衍生小RNA的全球概况及tRF-21-NB8PLML3E作为新的肥厚标志物的鉴定
Diagnostics (Basel). 2023 Jun 14;13(12):2065. doi: 10.3390/diagnostics13122065.
9
Physical Activity Over the Lifecourse and Cardiovascular Disease.一生中的体力活动与心血管疾病。
Circ Res. 2023 Jun 9;132(12):1725-1740. doi: 10.1161/CIRCRESAHA.123.322121. Epub 2023 Jun 8.
10
Cardiac RNase Z edited via CRISPR-Cas9 drives heart hypertrophy in Drosophila.通过 CRISPR-Cas9 编辑的心脏 RNase Z 可驱动果蝇心脏肥大。
PLoS One. 2023 May 25;18(5):e0286214. doi: 10.1371/journal.pone.0286214. eCollection 2023.